Pirfenidone for Restrictive Chronic Lung Allograft Dysfunction
Latest Information Update: 11 Jan 2023
At a glance
- Drugs Pirfenidone (Primary) ; Everolimus; Sirolimus; Tacrolimus
- Indications Lung transplant rejection
- Focus Adverse reactions
- Acronyms PIRCLAD
- 25 Apr 2022 Status changed from active, no longer recruiting to completed.
- 21 Oct 2020 Preliminary results assessing the safety and tolerability of pirfenidone in lung recipients, who require stable immunosuppression and are at risk of adverse events (AE) from polypharmacy, presented at the CHEST Annual Meeting 2020 by Annual Meeting of the American College of Chest Physicians.
- 21 Oct 2020 Interim Results (n=8) presented at the CHEST Annual Meeting 2020 by Annual Meeting of the American College of Chest Physicians